Influenza PA endonuclease — Drug Target

All drugs that target Influenza PA endonuclease — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Cap-dependent endonuclease inhibitor

Phase 3 pipeline (1)

• Baloxavir Marboxil tablets · Jiaxing AnDiCon Biotech Co.,Ltd · Cap-dependent endonuclease inhibitor · Virology/Infectious Disease
  Baloxavir marboxil inhibits the influenza virus endonuclease, blocking viral cap-dependent transcription and preventing viral replication.